Sohini Das retweetledi

Global #drugmakers are prioritising #China and #Japan for #GLP1 investments due to stronger pricing power and adoption, while #India remains a large but price-sensitive market with slower premium uptake.
Read more: mybs.in/2g5RkkW | @sohinidastweets
Download BS app: bit.ly/_BS_App

English















